24140-98-5

24140-98-5 structure

Name: 2-CMDO
Chemical Name: 1-(3-chlorobenzo[b][1]benzoxepin-5-yl)-4-methylpiperazin-4-ium,(Z)-4-hydroxy-4-oxobut-2-enoate
CAS Number: 24140-98-5
Molecular Formula: C₂₃H₂₃ClN₂O₅
Molecular Weight: 442.89200
Catalog: Signaling Pathways GPCR/G Protein Dopamine Receptor
Create Date: 2017-07-01 02:45:17
Modify Date: 2024-04-01 19:35:55
RMI-61140 is an orally active neuroleptics. RMI-61140 decreases spontaneous motility and muscle tone in mice. RMI-61140 increases barbit urate-induced sleep and causes eyelid ptosis. RMI-61140 can be used for schizophrenia research[1].

Name	1-(3-chlorobenzo[b][1]benzoxepin-5-yl)-4-methylpiperazin-4-ium,(Z)-4-hydroxy-4-oxobut-2-enoate
Synonyms	1-(3-chlorobenzo[b][1]benzoxepin-5-yl)-4-methylpiperazin-4-ium Piperazine,1-(8-chlorodibenz(b,f)oxepin-10-yl)-4-methyl-,(Z)-2-butenedioate (1:1) Piperazine,1-(8-chlorodibenz(b,f)oxepin-10-yl)-4-methyl-,maleate (1:1) N-(8-Chloro-dibenzo(b,f)oxepin-10-yl)-N'-methylpiperazine maleate Piperazine,1-(8-chloro-10-dibenzo(b,f)oxepinyl)-4-methyl-,maleate Rmi 61,140

Description	RMI-61140 is an orally active neuroleptics. RMI-61140 decreases spontaneous motility and muscle tone in mice. RMI-61140 increases barbit urate-induced sleep and causes eyelid ptosis. RMI-61140 can be used for schizophrenia research[1].
Related Catalog	Signaling Pathways >> GPCR/G Protein >> Dopamine Receptor Signaling Pathways >> Neuronal Signaling >> Dopamine Receptor Research Areas >> Neurological Disease
References	[1]. Coscia L, et al. Pharmacological properties of new neuroleptic compounds. Arzneimittelforschung. 1975 Sep;25(9):1436-42.